Senior international Access & Policy leader, Anh has nearly two decades of experience in Value-Based Healthcare, for better patient access to innovations.

She has enabled successful commercialisation of innovations across pharmaceuticals, medical devices, diagnostics, and digital health. Through optimal access & payment strategy, evidence-based value creation, market shaping and partnerships, she not only unlocked access and new revenue streams in competitive markets, but also driven policy change and sustainable adoption of innovations.

She is skilled in building and leading high-performing teams, scaling capabilities, and integrating cross-functional collaboration to accelerate product adoption. At NovoNordisk as APAC Senior Director, she spearheaded the transformation of Market Access, Pricing, Public Affairs & Sustainability functions into an integrated strategic commercial growth driver, establishing a clear roadmap to expand a $1.1B business in APAC region. At Abbott, she built the Market Access function from scratch, delivering $2.1M incremental business impact in the first year. She pioneered advocacy efforts that resulted in multi-lateral collaborations to expand access to Digital Health, diagnostics and Precision Medicine.

Her contributions to the field have been widely recognized, and she has been a regular speaker at major international conferences, providing valuable insights on topics such as digital health, health data, access and reimbursement.

TECHNOLOGIES: Medical Devices, Digital Health, Diagnostics, Pharmaceuticals

THERAPEUTIC AREAS: Immunology (Psoriasis, Rheumatology, Inflammatory Bowel Diseases), Cardiometabolics (Obesity, Diabetes, cardiovascular, MASH), Infectious Diseases (HIV, TB, Hepatitis, Respiratory), Orthopaedics, Rare Diseases, Neurosciences (Schizophrenia, Alzheimer, Epilepsy), Orthopaedics, Biosurgery/haemostasis

INTERNATIONAL EXPERIENCE: France, APAC (Australia, China, Japan, South Korea, Taiwan, India cluster, South East Asia…)